comparemela.com

Latest Breaking News On - Lank center - Page 18 : comparemela.com

JNM Releases Consensus on Lu-177 PSMA-617 Therapy Use

JNM Releases Consensus on Lu-177 PSMA-617 Therapy Use
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesMemorial sloan kettering cancer centerNew yorkUniversity of minnesotaSan franciscoUniversity of california san franciscoDana farber cancer instituteUniversity of washingtonOliver sartorHeather jaceneAmir iravaniScottt tagawaAliciak morgansMary ellen taplinMichaelj morrisLisa bodei

Dr Ravi on the Use of Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC

Praful K. Ravi, MB, BChir, MRCP, discusses the use of prostate-specific membrane antigen-targeted therapies in metastatic castration-resistant prostate cancer, highlighting the use of the targeted radioligand lutetium Lu 177 vipivotide tetraxetan.

Prafulk raviHarvard medical schoolDana farber cancer instituteLank centerGenitourinary oncologyScience summitOnclive tvPrecision medicine in oncology

Dr Sun on the Relationship Between Clonal Hematopoiesis and Cardiovascular Disease in RCC

Maxine Sun, PhD, MPH, discusses the association between clonal hematopoiesis and cardiovascular disease in patients with renal cell carcinoma

Maxine sunDana farber cancer instituteLank centerGenitourinary oncologyUnited kingdom biobankOnclive tvRenal cell carcinomaKidney cancer research summitClonal hematopoiesisCardiovascular disease

It s a Time of Hope for Kidney Cancer

With new treatments being explored, it’s an exciting time for patients with kidney cancer, an expert explained.

Toni choueiriKidney cancer research summitDana farber cancer instituteInternational strategicLank centerCancer research summitGenitourinary oncologyInternational strategic initiativesNancy kohlberg professorHarvard medical schoolKidney cancer

Dr Choueiri on Trials in Progress in Advanced Renal Cell Carcinoma

Toni K. Choueiri, MD, discusses ongoing trials in advanced renal cell carcinoma.

Tonik choueiriNancy kohlbergDana farber cancer instituteKidney cancer centerHarvard medical schoolLank centerGenitourinary oncologyNancy kohlberg chair

vimarsana © 2020. All Rights Reserved.